SECUKINUMAB

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Approval Year

Name

Type

Language

SECUKINUMAB

Official Name

English

SECUKINUMAB (GENETICAL RECOMBINATION)

Preferred Name

English

AIN457

Code

English

AIN-457

Code

English

IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS IL17A (INTERLEUKIN 17A, IL-17A)), HOMO SAPIENS MONOCLONAL ANTIBODY

Common Name

English

COSENTYX

Brand Name

English

SECUKINUMAB [USAN]

Common Name

English

Secukinumab [WHO-DD]

Common Name

English

AIN457A

Code

English

SECUKINUMAB [JAN]

Common Name

English

SECUKINUMAB [PURPLE BOOK CDER]

Common Name

English

secukinumab [INN]

Common Name

English

SECUKINUMAB [MI]

Common Name

English

Classification Tree Code System Code

EMA ASSESSMENT REPORTS

COSENTYX (AUTHORIZED: ARTHRITIS, PSORIATIC)

Created by admin on Mon Mar 31 21:04:22 GMT 2025 , Edited by admin on Mon Mar 31 21:04:22 GMT 2025

WHO-ATC

L04AC10

Created by admin on Mon Mar 31 21:04:22 GMT 2025 , Edited by admin on Mon Mar 31 21:04:22 GMT 2025

WHO-VATC

QL04AC10

Created by admin on Mon Mar 31 21:04:22 GMT 2025 , Edited by admin on Mon Mar 31 21:04:22 GMT 2025

NDF-RT

N0000191495

Created by admin on Mon Mar 31 21:04:22 GMT 2025 , Edited by admin on Mon Mar 31 21:04:22 GMT 2025

NCI_THESAURUS

C574

Created by admin on Mon Mar 31 21:04:22 GMT 2025 , Edited by admin on Mon Mar 31 21:04:22 GMT 2025

NCI_THESAURUS

C20401

Created by admin on Mon Mar 31 21:04:22 GMT 2025 , Edited by admin on Mon Mar 31 21:04:22 GMT 2025

FDA ORPHAN DRUG

281309

Created by admin on Mon Mar 31 21:04:22 GMT 2025 , Edited by admin on Mon Mar 31 21:04:22 GMT 2025

Code System Code Type Description

CAS

1229022-83-6

Created by admin on Mon Mar 31 21:04:22 GMT 2025 , Edited by admin on Mon Mar 31 21:04:22 GMT 2025

PRIMARY

DAILYMED

DLG4EML025

Created by admin on Mon Mar 31 21:04:22 GMT 2025 , Edited by admin on Mon Mar 31 21:04:22 GMT 2025

PRIMARY

NCI_THESAURUS

C152315

Created by admin on Mon Mar 31 21:04:22 GMT 2025 , Edited by admin on Mon Mar 31 21:04:22 GMT 2025

PRIMARY

ChEMBL

CHEMBL1743068

Created by admin on Mon Mar 31 21:04:22 GMT 2025 , Edited by admin on Mon Mar 31 21:04:22 GMT 2025

PRIMARY

SMS_ID

100000126309

Created by admin on Mon Mar 31 21:04:22 GMT 2025 , Edited by admin on Mon Mar 31 21:04:22 GMT 2025

PRIMARY

JAPANESE REVIEW

COSENTYX (INITIAL APPROVAL)

Created by admin on Mon Mar 31 21:04:22 GMT 2025 , Edited by admin on Mon Mar 31 21:04:22 GMT 2025

PRIMARY

APPROVED DECEMBER 2014

MERCK INDEX

m11827

Created by admin on Mon Mar 31 21:04:22 GMT 2025 , Edited by admin on Mon Mar 31 21:04:22 GMT 2025

PRIMARY

USAN

XX-120

Created by admin on Mon Mar 31 21:04:22 GMT 2025 , Edited by admin on Mon Mar 31 21:04:22 GMT 2025

PRIMARY

CAS

875356-43-7

Created by admin on Mon Mar 31 21:04:22 GMT 2025 , Edited by admin on Mon Mar 31 21:04:22 GMT 2025

ALTERNATIVE

EVMPD

SUB33242

Created by admin on Mon Mar 31 21:04:22 GMT 2025 , Edited by admin on Mon Mar 31 21:04:22 GMT 2025

PRIMARY

WIKIPEDIA

Secukinumab

Created by admin on Mon Mar 31 21:04:22 GMT 2025 , Edited by admin on Mon Mar 31 21:04:22 GMT 2025

PRIMARY

DRUG CENTRAL

4934

Created by admin on Mon Mar 31 21:04:22 GMT 2025 , Edited by admin on Mon Mar 31 21:04:22 GMT 2025

PRIMARY

LACTMED

Secukinumab

Created by admin on Mon Mar 31 21:04:22 GMT 2025 , Edited by admin on Mon Mar 31 21:04:22 GMT 2025

PRIMARY

RXCUI

1599788

Created by admin on Mon Mar 31 21:04:22 GMT 2025 , Edited by admin on Mon Mar 31 21:04:22 GMT 2025

PRIMARY

RxNorm

NDF-RT

N0000191494

Created by admin on Mon Mar 31 21:04:22 GMT 2025 , Edited by admin on Mon Mar 31 21:04:22 GMT 2025

PRIMARY

Interleukin-17A Antagonists [MoA]

INN

9182

Created by admin on Mon Mar 31 21:04:22 GMT 2025 , Edited by admin on Mon Mar 31 21:04:22 GMT 2025

PRIMARY

JAPANESE REVIEW

COSENTYX (PARTIAL CHANGE APPROVAL)

Created by admin on Mon Mar 31 21:04:22 GMT 2025 , Edited by admin on Mon Mar 31 21:04:22 GMT 2025

PRIMARY

APPROVED DECEMBER 2015

IUPHAR

8078

Created by admin on Mon Mar 31 21:04:22 GMT 2025 , Edited by admin on Mon Mar 31 21:04:22 GMT 2025

PRIMARY

DRUG BANK

DB09029

Created by admin on Mon Mar 31 21:04:22 GMT 2025 , Edited by admin on Mon Mar 31 21:04:22 GMT 2025

PRIMARY

FDA UNII

DLG4EML025

Created by admin on Mon Mar 31 21:04:22 GMT 2025 , Edited by admin on Mon Mar 31 21:04:22 GMT 2025

PRIMARY

ACTIVE MOIETY


					DLG4EML025